Experienced in Leukemia

Dr. Erika D. Friehling

Pediatric Hematology Oncology
4401 Penn Avenue, Plaza Building, 
Pittsburgh, PA 
Experienced in Leukemia
4401 Penn Avenue, Plaza Building, 
Pittsburgh, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Erika Friehling is a Pediatric Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Friehling is rated as an Experienced provider by MediFind in the treatment of Leukemia. Her top areas of expertise are Acquired Amegakaryocytic Thrombocytopenia, Chromosome 7p Deletion, Leukemia, and Juvenile Myelomonocytic Leukemia (JMML).

Her clinical research consists of co-authoring 24 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 8 articles and participated in 1 clinical trial in the study of Leukemia.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatrics in PA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
View 5 Less Insurance Carriers -

Locations

4401 Penn Avenue, Plaza Building, Pittsburgh, PA 15224
Call: 412-692-5325

Additional Areas of Focus

Dr. Friehling has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Pilot Study of Rituximab (RTX) and Third Party Latent Membrane Protein (LMP)-Specific Cytotoxic T-Lymphocytes (LMP-TC) in Pediatric Solid Organ Recipients (SOT) With EBV-Positive CD20-Positive Post-Transplant Lymphoproliferative Disease (PTLD)
A Pilot Study of Rituximab (RTX) and Third Party Latent Membrane Protein (LMP)-Specific Cytotoxic T-Lymphocytes (LMP-TC) in Pediatric Solid Organ Recipients (SOT) With EBV-Positive CD20-Positive Post-Transplant Lymphoproliferative Disease (PTLD)
Enrollment Status: Completed
Publish Date: January 26, 2026
Intervention Type: Biological
Study Drugs: Allogeneic LMP1/LMP2-Specific Cytotoxic T-Lymphocytes, Rituximab
Study Phase: Phase 2
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
Enrollment Status: Active_not_recruiting
Publish Date: December 01, 2025
Intervention Type: Other, Drug, Biological
Study Drugs: Bleomycin, Brentuximab, Cyclophosphamide, Doxorubicin, Etoposide, Methylprednisolone, Prednisone, Vincristine
Study Phase: Phase 3
A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Biological, Drug, Procedure, Radiation
Study Drugs: Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide Phosphate, Filgrastim, Nivolumab, Pegfilgrastim, Prednisolone, Prednisone, Rituximab, Rituximab+Hyaluronidase Human, Vincristine Sulfate
Study Phase: Phase 3
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Drug, Biological, Radiation
Study Drugs: Erwinia Asparaginase, Blinatumomab, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin Hydrochloride, Leucovorin Calcium, Mercaptopurine, Methotrexate, Pegaspargase, Prednisolone, Prednisone, Thioguanine, Vincristine Sulfate
Study Phase: Phase 3
View 3 Less Clinical Trials

23 Total Publications

TRAF7-Mutated Myxoid and Spindle Cell Mesenchymal Tumor Occurring in a Pediatric Patient in the Post-Transplant Setting: Expanding the Spectrum of TRAF7-Mutated Tumors.
TRAF7-Mutated Myxoid and Spindle Cell Mesenchymal Tumor Occurring in a Pediatric Patient in the Post-Transplant Setting: Expanding the Spectrum of TRAF7-Mutated Tumors.
Journal: Genes, chromosomes & cancer
Published: October 01, 2025
View All 23 Publications
Similar Doctors
Experienced in Leukemia
Dr. Jenny Ruiz
Pediatric Hematology Oncology
Experienced in Leukemia
Dr. Jenny Ruiz
Pediatric Hematology Oncology
4401 Penn Ave, 
Pittsburgh, PA 
 (0.1 miles away)
412-692-7593
Languages Spoken:
English
See accepted insurances

Jenny Ruiz is a Pediatric Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Ruiz is rated as an Experienced provider by MediFind in the treatment of Leukemia. Her top areas of expertise are Leukemia, Acute Lymphoblastic Leukemia (ALL), Ewing Sarcoma, and Osteosarcoma.

Experienced in Leukemia
Dr. Erica L. Braverman
Pediatric Hematology Oncology
Experienced in Leukemia
Dr. Erica L. Braverman
Pediatric Hematology Oncology
4401 Penn Ave, 
Pittsburgh, PA 
 (0.1 miles away)
412-692-5437
Languages Spoken:
English
See accepted insurances

Erica Braverman is a Pediatric Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Braverman is rated as an Experienced provider by MediFind in the treatment of Leukemia. Her top areas of expertise are Leukemia, Graft Versus Host Disease (GvHD), and Immune Thrombocytopenic Purpura (ITP).

Experienced in Leukemia
Dr. Steven Fein
Pediatric Hematology Oncology
Experienced in Leukemia
Dr. Steven Fein
Pediatric Hematology Oncology

University Of Pittsburgh Physicians

200 Lothrop St, Muh 4 East, 
Pittsburgh, PA 
 (1.7 miles away)
412-383-1370
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Steven Fein is a Pediatric Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Fein is rated as an Advanced provider by MediFind in the treatment of Leukemia. His top areas of expertise are Alpha Thalassemia, Blood Clots, Anemia, Bone Marrow Aspiration, and Splenectomy.

VIEW MORE LEUKEMIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Friehling's expertise for a condition
ConditionClose
        • Experienced
        • Acquired Amegakaryocytic Thrombocytopenia
          Dr. Friehling is
          Experienced
          . Learn about Acquired Amegakaryocytic Thrombocytopenia.
          See more Acquired Amegakaryocytic Thrombocytopenia experts
        • Acute Lymphoblastic Leukemia (ALL)
          Dr. Friehling is
          Experienced
          . Learn about Acute Lymphoblastic Leukemia (ALL).
          See more Acute Lymphoblastic Leukemia (ALL) experts
        • Chromosome 7p Deletion
          Dr. Friehling is
          Experienced
          . Learn about Chromosome 7p Deletion.
          See more Chromosome 7p Deletion experts
        • Juvenile Myelomonocytic Leukemia (JMML)
          Dr. Friehling is
          Experienced
          . Learn about Juvenile Myelomonocytic Leukemia (JMML).
          See more Juvenile Myelomonocytic Leukemia (JMML) experts
        • Leukemia
          Dr. Friehling is
          Experienced
          . Learn about Leukemia.
          See more Leukemia experts
        • RASopathies
          Dr. Friehling is
          Experienced
          . Learn about RASopathies.
          See more RASopathies experts
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile
        For Patients
        • Our Story
        • How MediFind Works
        • Conditions A-Z
        • Doctor Directory
        • Symptoms Directory
        • Procedures Directory
        • Treatment Directory
        • Drug Directory
        • Infusion Center Finder
        • FAQ
        • Contact Us
        For Providers and Practices
        • Claim Your Profile
        • Newsroom
        Business Solutions
        • Provider
        • Network Solutions
        Additional Resources
        • Consumer Health Data Privacy Policy
        • Privacy Policy
        • Terms of Use
        • Advertising Policy
        • Content Policy
        Subscribe to our newsletter

        Sign up to stay informed about MediFind and get wellness sent your way.

        Close

          By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

          Bullet PinMediFind
          Follow us on
          This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
          © 2026 All Rights Reserved

          Request an Appointment

          If you are experiencing a medical emergency, call 9-1-1.

          MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

          Patient Details

          This information is for the patient who will be seen at the appointment.

            Close

            Returning patient? Use your address on file with the provider.

            Insurance Details

            Please provide information of the primary insurance holder as the practice may require this information to schedule.

            Insurance Provider *
            Insurance ProviderClose

            Appointments Details

            Let’s get more information about your appointment.

                    0 / 1000
                    0 / 1000
                    By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.